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ABSTRACT One of the dinical manifestatons of Alzheimer's disease is the deposition of the 39-43 residue amyloid-(3 (A()
peptide in aggregated fibrils in senile plaques. Characterization of the aggregation behavior of A is one of the critcal issues
in understanding the role of A, in Fe disease process. Using solution hydrodynamics, A,8 was observed to form three types
of species in phosphate-buffered saline: insoluble aggregates with sedimentation coefficents of -50,000 S and molecular
masses of -1 09 Da, 'soluble aggregates' with sedimentation coefficients of -30 S and masses of - 106 Da, and monomer.
When starting from moKomer, the aggregation kinetics of A,B 1-40 (A,840) and A,l 1-42 (Af342), alone and in combination, reveal
large differences in the tendency of these peptides to aggregate as a function of pH and other solution conditons. At pH 4.1
and 7.0-7.4, aggregation is signficantly slower than at pH 5 and 6. Under all conditions, aggregation of the longer A(142 was
more rapid than Af340. Oxidation of Met-35 to the sulfoxide in A,340 enhances the aggregation rate over that of the nonoxidized
peptide. Aggregation was found to be dependent upon temperature and to be srongly depenrent on peptide concentraion and
ionic strength, indicating that aggregation is dnven by a hydrophobic effect When Af640 and A(342 are mixed together, A(340
retards the aggregation of A1342 in a concentraton-dependent manner. Shorter fragments have a decreasing ability to interfere
with A842 aggregation. Conversely, the rate of aggregation of AJ340 can be signfiantly enhanced by seeding slow aggregating
solubons with preformed aggregates of A,842. Taken together, the inhibition of A342 aggregation by Af340, the seeding of A4340
aggregation by A(342 aggregates, and the chemical oidation of A(340 suggest that the relafive abundance and rates of pro-
duction of different-leng]t A(3 and its exposure to radical damage may be factors in the accumulation of A,3 in plaques in vivo.
INTRODUCTION
The formation of extracellular deposits of neuritic (se-
nile) plaques is one hallmark of Alzheimer's disease
(AD). The major component of these plaques is amyloid-,3
(A(B), a 39-43-residue peptide (Glenner and Wong, 1984;
Kang et al., 1987). The sequence of A43 1-42 is:
DAEFR5HDSGY'OEVHHQ 5KLVFF2mAEDVG 2SNKGA3O-
IHLGLM35VGGVV4'IA A46 is derived by proteolytic cleav-
age of the transmembrane region of the 110-135-kDa amy-
loid precursor protein (IBPP; Goldgaber et al., 1987; Kang
et al., 1987; Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi
et al., 1988). Evidence suggests that accumulation of A,3 and
formation ofthe neuritic plaques may play a pathological role
in the disease (Kowall et al., 1991; Yankner, 1992; Krafft,
1993; Selkoe, 1993). Reports from in vitro toxicity studies
have suggested that soluble AJ3 is nontoxic, whereas aggre-
gated A3 is toxic (Pike et al., 1991; Burdick et al., 1992;
Mattson and Rydel, 1992; Yankner, 1992; Pike et al., 1993;
Giordano et al. 1994). Soluble A(3 is present as a normal
extracellular product in a variety of cell lines (Haass et al.,
1992) and is found at comparable levels in the cerebrospinal
fluid of age-matched AD and normal patients (Seubert et al.,
1992; Shoji et al., 1992).
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AJ3 forms antiparallel (3-pleated sheets that aggregate into
amyloid fibrils that exhibit positive Congo Red staining
(Glenner, 1980; Kirschner et al., 1987; Turnell and Finch,
1992).Anumber of techniques, including circular dichroism,
nuclear magnetic resonance (NMR), and infrared, have been
employed to characterize the secondary molecular structure
and conformation of AJ3 (Masters et al., 1985; Halvserson
et al., 1990; Fraser et al., 1991; Hilbich et al., 1991; Spencer
et al., 1991; Barrow et al., 1992; Fraser et al., 1992;
lAnsbury, 1992; Zagorski and Barrow, 1992). The degree of
(-sheet character and transitions to either a-helix or random
coil have proven to be strongly dependent upon the solution
characteristics. Observations of molecular structural vari-
ability have been attnbuted to a number of physical and en-
vironmental characteristics, including the length of the A(3
fragment, peptide concentration, age of the sample, presence
of organic solvents, temperature, solution pH, and ionic
strength (Fraser et al., 1991; Hilbich et al., 1991; Barrow
et al., 1992; Fraser et al., 1992; Zagorski and Barrow, 1992;
Otvos et al., 1993).
The fibrillar structure of A3 aggregates has been inves-
tigated with electron microscopy, x-ray diffraction, and
light scattering (Gorevic et al., 1986; Kirschner et al., 1987;
Halvserson et al., 1990; Caputo et al., 1992; Fraser et al.,
1992; Caputo et al., 1993; Inouye et al., 1993). Reports in-
dicate that the fibrils formed from purified A(3 are relatively
straight with a diameter of 5 mu and periodic twists (Fraser
et al., 1992). These structures have generally correlated with
the structures observed of fibrils in senile plaques from AD
brains (Kirschner et al., 1986).
It is reasonable to assume, a priori, that the ability of A(3
to accumulate in senile plaques in vivo strongly depends on
1216
Amyloid-f Aggregation
at least two factors, local concentration and the kinetics of
aggregation. If A(3 aggregation is slow in vivo, it may
be cleared by proteolytic degradation before its deposition
(Hyman et al., 1993; Ladror et al., 1993, 1994, Suzuki et al.,
1994). Conversely, if the seeded aggregate structure becomes
resistant to proteolysis in vivo more rapidly than it is de-
graded, the seeds will grow into larger aggregates and senile
plaques could form. There have been several investigations
of the kinetics of Af3 aggregation (Tomski and Murphy,
1992; Jarrett and Lansbury, 1993; Jarrett et al., 1993; Shen
et al., 1993; Snyder et al., 1993a,c). Most of the work has
focused on kinetic events that occur over the course of hours
to days. In general, conditions that favor (-sheet structure
also enhance aggregation rates (Tomski and Murphy, 1992;
Jarrett and Lansbury, 1993; Jarrett et al., 1993).
Observations regarding aggregate size and structure, as
well as the kinetics of aggregation, have exhibited consid-
erable variability as a result of different peptide-handling
procedures and techniques employed to monitor and char-
acterize aggregation behavior (Knauer et al., 1992; Simmons
et al., 1993, 1994; Snyder et al., 1993b,c). One cause of the
discrepancy regarding A(3 aggregation and toxicity is the
method of dissolving and handling A(3. Typically, experi-
ments have been performed by directly transferring Af3 from
a lyophilized solid to the solution conditions employed for
aggregation, structure, or toxicity studies (Hilbich et al.,
1991; Burdick et al., 1992; Tomski and Murphy, 1992).
There has been no consideration for the effect of high local
A(3 concentrations on aggregation behavior during the non-
homogeneous solvation process. At high concentrations of
synthetic A43, variations in acid or water content may ac-
centuate the nonhomogeneous distribution during mixing of
the lyophilized solid. Furthermore, little regard has been
shown for potential aggregation in intermediate A(3 solutions
used between concentrated stock solutions and dilute final
solutions. At intermediate dilutions, A(3 remains relatively
concentrated, whereas organic solvent concentrations are re-
duced, which can lead to rapid aggregation. Besides varia-
tions in Af3 solvation, differences exist in the techniques
employed to characterize the degree of A(3 aggregation. The
sensitivity of dye staining such as thioflavine T to either
small soluble aggregates or rapidly formed aggregates with
little structural integrity remains unclear (LeVine, 1993). The
effect of SDS on the stability of A(3 aggregates precludes gel
electrophoresis as a reliable quantitative technique for as-
sessing aggregation. Finally, a variety of studies have been
conducted with the implicit presumption that all aggregated
A(3 is removed by centrifugation at 10,000-100,000 x g
(Burdick et al., 1992; Waite et al., 1992; LeVine, 1993).
A paradigm for studying amyloid aggregation depends
upon the ability to define an initial solute physical state, to
monitor the transition process from an initial state to a final
state, and to define the final (equilbrium) state (Snyder et al.,
1993a-c). Rates of aggregation, in vivo, that are so sluggish
that they preclude accumulation in competition with pro-
teolysis cannot be considered relevant (Hyman et al., 1993;
Ladror et al., 1993, 1994; Suzuki et al., 1994). Therefore, we
have undertaken a systematic investigation of the propensity
of AB3 to aggregate under conditions in which peptide ac-
cumulation would be expected to compete with physiological
degradation. In this work, we descnbe the aggregation of A(
from a hydrodynamically defined, monomeric starting state
to a fibrillar final state. We find that kinetics are strongly
dependent on fragment length, pH, concentration, seeding,
and ionic strength. We further demonstrate that aggregation
kinetics of the more hydrophobic A43 1-42 (A(342) can be
selectively inhlbited, in a specific and dose-dependent fash-
ion, by the more soluble A43 1-40 (A(340). In addition, we
demonstrate that oxidation of the single Met-35 residue in
A(340 to the more polar sulfoxide form, (AJ340 M[O]), en-
hances aggregation rate. From the dependence of aggrega-
tion kinetics on relative concentrations of A(340 and A(342,
we suggest that selectivity of cleavage in the carboxy ter-
minus of APP and the potential for Met-35 oxidation may be
factors in the accumulation of A46 in senile plaques.
MATERIALS AND METHODS
Peptide synthesis and purifiation
The methods used for peptde synthesis and the characterizaion of the
resulting pepqdes are briefly summarized. Solid-phase peptide synthesis
was carried out on an Applied Biosystems (Foster City, CA) Model
430A peptide synthesizer operatig with Fmoc chemistry based on
dicyclohexylcarbodiimide-catalyzed formation ofl-hydroxytiazole ester in
N-methylpyrolidone (NM) and dichloromethane (DCM) co-solvent. Fmoc
removal (deprotection of amino groups) was achieved with 20% piperidine
in NMP. The side chain protecting groups were as foLows: Ser and Tyr,
Ot-Bu; Asn and Gin, C(O)NH-Trityl; Asp and Glu, C02-t-Bn, His, Trityl;
Lys, Boc-NH; Arg, N-(2v 5,7,8-pentamethylchroman-6sulfonyl). All
natural amino acids were purchased from ABI. Fmoc-Met oxide for the
synthesis of Af340 Met-35[01 (A,l40 M(OJD was either prepared by oxi-
dation of Fmoc-Met with m-chloroperbenzoic acid in DCM or purchased
from Bachem (Torrance, CA). ABI p-hydroxymethylphenoxymethyl resin
with a substitution level of 0.85 mmol/g was used for synthesis. A standard
double-loading cycle involving coupling in the presence of p-dimethyl-
aminopyridine was used to load the first residue on to the resin. Coupling
of all subsequent resdues was achieved using standard double-couplng
cycles with acetyl cappmg supplied with the instument In our hands syn-
theses performed as descnbed above exhibited a typical coupling efficiency
of 99.6% by ninhydrin analysis.
Upon completion of a synthesis, the peptide resin was treated with a
mixture of trifluoroacetic acid (TA, 93%) and a scavenger cocktail (7%)
composed of ethylene dithiol, anisole, and ethylmethyl sulfide in a 1:3:3
ratio for 3-4 h. The cleavage reagents were typically used at 20 mug of
peptide resin At the end of cleavage the resin was removed by filration and
the solvents were evaporated. The crude peptide was precipitated with di-
ethyl ether and collected. The amount of crude peptide obtained typically
coresponded to -95% of the expected theoretical yieldbasedon the amount
of resin used. The crude peptides were rouiely analyzed by reversed phase
high-performance liquid chromatography (RP-HPLC) and mass spectrom-
etry. Preparative peptide isolatons were performed using a 40-mm C8 col-
umn (300 A, 12 pm) at 45 ml/min Before elution of each peptide the
acetonitrile (ACN) gradient was reduced to 0.6% ACN/min to broaden the
eluting peak. Only the center of each peak was collected (-85% of peak
area). The pooled HPLC fractions were lyophilized and the products further
analyzed by analytical RP-HPLC and electrospray ionization mass spec-
trometry (ESI-MS) to establish purity. Typical purity values were >95% for
A,840 and >85% for A,42.
Sample preparation
A, samples were stored in lyophilized form at room temperature, and were
dissolved in stock sohltions in either dimethyl sulfoxide (DMSO), 30%
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ACN with 0.1% TFA (ACNfITfA), hexafluoroisopropanol (HFIP), or H20
at concentrations up to 30 mg/ml (-6.5 mM) Dilutio was accomplished
in one step from the concentrated stocks into the final buffer, avoiding
intermediate solutns with high A,B concentrations between the starting
stock and final soluti. Samples were dissolved in either of two buffers:
phosphate-buffered salin (PBS) cmposed of phoshate (10-50 mM),
NaCI (0-500 mM, pH 7.40); or a wide-range pH buffer composed ofHOAc
(20mM) MES (20mM) Tris (20m), glycine (20mM), NaCI (150 mM,
pH 3-9).
Analyfical ultracetrfugation measuremetrs
Sedimentation equilibrinm and velocity measurements were performed on
a Beckman (Palo Alto, CA) XL-A analytical ultracentrifue with an An6OTi
rotor (Holzman and Snyder, 1994). Most experiments were carried out at
23.0°C. Equilibrium rums were performed on 110-(} samples over the rotor
velocity range 3000-60,000 rpm. Samples were centifuged for at least 20
h to reach equlibrim and signals were averaged 4 to 16 times. Data were
analyzed for solute molecular weights as recently described (Holzman and
Snyder, 1994) Velocity rums were performed on 300-450-gl samples over
the rotor velocity range of 1000-30,000 rpm. Analysis of velocity data for
sedimentation and diffusion coefficients for single solutes and multiple,
noninteracting solutes were based on a form of Faxen's two-component
solution to the Lamm equation, as descnrbed by Fujita (1962). The useful
expression is:
(coe )[ ( (xe r)/1) (1)
where x = (r/rj), T = 2sw2t, e - 2DIs(ir2, I) is the error function of the
term enclosed in brackets, r is the radial position, ro is the radial position
of the meniscus, a is the radial rotor velocity, t is the time, and s and D are
the sedimentation and diffusion coefficients, respectively. The sedimenta-
tion coefficient is reported in Svedbergs (S, 10-13 s') and the diffusion
coefficient in Fcks (107 cm2/s). Under sitable conditions (Fujita, 1962),
Eq. 1 can be used to approximate the profile of a sedimenting boundary
(Holzman and Snyder, 1994). For heterogeneous samples or samples with
multiple sedimenting components with different vahles of s and D, the
sedimenting boundary can be represented as a linear sum of terms identical
to Eq. 1, where each term represents a component with specific value of s
and D (Holzman and Snyder, 1994). A sampe with multiple sedimenting
components of similar hydrodynamic propertes can be fit to a model that
assumes only one sedimenting species. The simplified model will yield an
average sedimentation coefficient and an overestimated diffusion coeffi-
cient that compensates for the spreading sedimenting boundary.
When s and D are well defined, the molecular mass and the shape of the
sedimenting species can be determined by:
sRT
,4'D(I-,Vp) (2)
where R is the universal gas constant, V is the partial specific volume of the
sedimentmg species and p is the solvent density. With a distnbuibon of
sedimentig specis, large uncertaintes in the diffusion coefficient exist,
and average sedimentaton coefficients can be employed to estimate average
molecular masses:
Mw X 6000s"' (3)
Eq. 3 is an empirical relationship employed to estimate molecular masses
of aqueous solutions of proteins (Chervenka, 1973).
Stafford (1992a,b) has developed another method for caluating the
apparent sedimentation coefficient distribution, g*(s),, for sedimenting spe-
cies. This method does not retain any informatin regarding the diffion
coefficient of the sedimenting species. We employ the algorithm "dcdt
developed by Stafford to determine g*(s),.
Dynamic light scattering
Dynamic light scatering (DLS)was performed on a Nicomp (Santa Barbara,
CA) 370 instument equipped with a Coherent (Santa Clara, CA) 304 argon
ion laser. Samples were centrifuged to remove large materia, and samples
were analyzed for - 10 min. The results are presented as a mean Gaussian
diameter (MGD). The cubic dependence of scattering on particle size (An-
dreu and Timasheff, 1986) causes the MGD to be biased toward larger-sized
partides.
Kinet measurements of aggregato
Aggregation kinetics were monitored after rapid manual dilution/mixing of
the A,8sample from a 30-mg/mi (6.5 mM) stock solution in DMSO or HFIP
into the desired buffer. After dissolving the A$8 sample in DMSO, the so-
luion was centrifuged at 10,000 x g for 5 min to remove undissolved
material. Mixingwas accomplished in the cuvette by rapidly drawing up and
delivering the solution 10 to 15 times with a pipette equipped with a small-
bore 200-pil disposable tip or by vortexing the sample immediately upon
dilution. Fmal A,J concenhations were kept in the range of 0.05-2.0 mg/ml
(10-450 FM), with most measurements at 0.2 mg/ml (45 jiM). Coaggre-
gation and aggregation inhibition measurements were accomplished by pre-
mixing the stock DMSO solutions before dilution into the desired buffer.
Seedng experiments were accomplished by mixng the seed A3 sample into
the desired buffer as descnrbed, allowing aggregtion to occur, and then
mixing in the secondary AJI stock solution (dissolved in DMSO) as before.
Aggregaton was monitored by folowing the change in turbidity with a
Hewlett Packard (Palo Alto, CA) 8452 diode array spectrphotometer. Tur-
bidity was monitored at 350 nm on unagiat samples in a cuvette with a
05-1.0-cm path length over the temperature range, 10-37C. Unless oth-
erwise noted, dilutio of AJ from its stock solution was accomplished im-
mediately before the start of data collection (within 1 min). Turbidity mea-
surements were compared with Rayleigh light-satering measuements and
similar behavior was observed.
Electron microscopy
Sampleswere colleced from the aggregation kinetics experiments about one
week after mixing. Samples (20 pl) were placed onto formvarcarbon-coated
specimen grids negatively stained with 2% p aid, and ex-
amined with a CM12 tansmission electron microscope (TEM) operating at
80 kV accelerating voltage and 60,000X magnification.
RESULTS AND DISCUSSION
A paradigm for examining the aggregation of
purified syntic A13
The method we employ for monitoring AI3 aggregation be-
havior is top ed from a clearly defined, monomeric start-
ing state to a fibrillar final state. We start by characterizing
the initial and final states and continue by monitoring the
transition between these two states. In this approach the ef-
fects of added agents on the aggregation process are moni-
tored during the transition.
RP-HPLC and ESI-MS were used as primary analytical
methods to establish the purity of the peptide. Excellent syn-
thetic results were obtained for the synthesis of AJ840 with
the desired product constituting at least 95% of the crude
product. The purity level is equal to or better than the Af840
samples employed in various studies where analytical data
for the peptides were given and comparisons could be made
(Burdick et al., 1992). The synthesis ofAf42 was more prob-
lematic, as unpurified peptide contained 80-85% of the de-
sired material, with the remainder being truncated peptides.
Routine purification of this peptide by HPLC to a single
sequence was unreliable because of its extraordinarily poor
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solubility and propensity to aggregate. These results are con-
sistent with the results ofothers in which A,842 samples were
produced by continuous solid-phase synthesis (Burdick et al.,
1992). As a test of purity water-soluble and water-insoluble
fractions ofA,642 were compared by mass spectroscopy after
centrifugation at 10,000 X g. No discernible differences be-
tween the samples were observed. These results indicate that
our aggregation experiments are monitoring AP42 at the
stated purity, not selectively monitoring more soluble
impurities.
To assess the degree of aggregation of Af842 in potential
purification solvents, we determined their MGD values by
DLS (Table 1). The MGD provides a qualitative indication
of aggregation but is strongly affected by presence of larger
species, even at low concentrations. In DMSO the 10 mg/ml
A,r42 solution was >99% monomeric with an equivalent di-
ameter of 2.4 nm. However, MGD values were skewed by
a small population of large aggregates to yield mean values
of 378 nm. Therefore the A,3 DMSO solutions were centri-
fuged for 10 min at 10,000 X g before use. When diluted into
the other solvents, A,842 tended to aggregate with time. In
either H20/TFA orACN this trend ofgrowing aggregate size
was observed. Aggregation was particularly severe in solvent
systems with trifluoroethanol exibiting large size and rapid
growth. The mixture, 50%v ACN and 50%o 2-propanol (2-Pr),
yielded the smallest aggregate sizes and the most stable be-
havior. We are currently investigating ACN/2-Pr as a puri-
fication solvent for A,42.
One possible strategy considered for improving the purity
of synthetic A,842 is a convergent fragment-coupling method
rather than continuous solid-phase synthesis (Hendrix and
Lansbury, 1992; Hendrix et al., 1992). The stated advantage
of this approach is that the smaller component fragments can
be highly purified before condensation, thereby limiting the
TABLE 1 Mean an diaer of 1 mgm AP42 in
oa sohvnts at various ages
Fresh 1.5 h 24 h
Solvent (mm) (nm) (nm)
DMSO* 378t
H20/0.1% TFA 36 96 263
ACN 27' 53 80
2-Pr 80' 96 187
TE 134 180
50% ACN/50% 2-Pr 15 20
50% ACN/50% TFE 138 90
50% 2-Pr/50% TFE 47 87
10% TFEA0.1% TEA/H20 29' 108 1747
50% TFE/0.1% TFA/H20 10o10 4061 4101
70% TFE/0.1% TFA/H20 * * 529
* In DMS0 A,r42 = 10 mg/mIL All other sampks were prepared by diluting
this starting solution tenfold with the indicated solvent. Therefore the
A,42 = 1 mg/ml and there is 10% DMS0 rmaining.
t Analysis indiated that 99% of the sample had a diameter of 2.4 nm,
which is probably monomer and the remainder distrbuted m the range
18-1000 am.
'Sattering intensity increased continuously, indicating rapid aggregation.
'ifluoroethanol
It is likely that a large aggregate sedimented out of the cuvette and has been
exccluded from the measurement.
** Unstable scatterng, probably due to severe aggregation during
measurement
number of peptides lacking one or two residues. In practice,
however, fragment-coupling approaches suffer from both
poor efficiency and yield. Finally, the potential for peptide
racemization during consecutive condensations must also be
addressed.
Dissoluton of the A3 peptide and hydrodynamic
characterstics of the initial and
aggregatd states
The aggregation states of A3 stock solutions were charac-
terized by analytical ultracentrifugation. Sedimentation equi-
librium and velocity measurements for A,3 were compared
in a series of stock solutions: DMSO, ACNfFfA, and H20
(Figs. 1 and 2). Both AJ340 and A(842 remained monomeric
in DMSO over a wide concentration range (Fig. 1, A and B).
After dispersion of solid peptide in ACNFTJFA, a solvent
composition commonly employed by researchers (Waite
et al., 1992; Yankner et al., 1990), large aggregates were
observed initially and increased in size over the course of
several days (Fig. 1, C and D). Attempts to dissolve A1340
in distilled H20 did not yield monomeric solutions; within
1-2 days molecular masses of-85 x 105 Da developed with
contributions from monomer representing less than 1% ofthe
total content (Fig. 2 A). A sample that was aged for one
month exhibited s - 55 S, which represents a molecular mass
on the order of 2 x 106 Da (Fig. 2 B). The nonzero baseline
in Fig. 2 B indicates that smaller species were also present,
but they were not analyzed for size or contribution.
The aggregation states of A(340 and A(342 were further
characterized in perdeuterated solvents, DMSO and ACN/
DCl by NMR (1 D). NMR spectra of Afi40 in deuterated
DMSO exhibited sharp lines that were concentration inde-
pendent (in DMSO) over the range of 5-18 mg/ml (not
shown). In comparison, in 30o deutrated ACN/0.1% DCI/
D20, spectral lines were broad and concentration dependent
across the same concentration range. These results are con-
sistent with a monomeric form of A3 in DMSO in com-
parison with an aggregated form in acidified ACN.
We also performed DLS measurements on solutions of
A(340 and A(342 in HFIlP (Pike et al., 1993), given that the
solvent density of HFIP is too high (p = 1.6) to perform
hydrodynamic measurements. At 30 mg/mnl (6.5 mM), both
A$40 and A842 had diameters in the range 1.5-2 nm in-
dicating that both AJ640 and Afr42 remained monomeric in
HF[P. To date, HFIP and DMSO are the only solvents that
we have observed to yield monomeric A( solutions reliably.
When an A1340 sample was aged in PBS at 450 FM (2
mg/ml), several ranges of species sizes were observed by
hydrodynamic analysis (Fig. 3). At 3000 rpm (650 x g),
large aggregates sedimented with s -50,000 S (Fig. 3 A).
These aggregates have molecular masses on the order of 1010
Da and are probably visible to the naked eye. Upon increase
of the rotor velocity to 30,000 rpm (65,000 x g), a second
species sedimented with s -30 S (Fig. 3 B). This represents
a smaller aggregate with a molecular mass of 106 Da, and
therefore an aggregate of 1000 Aj3 monomers. These latter
aggregates are not removable from solution by a typical
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FIGURE 1 Saimentatio analyses of A mdiifferent solvents. (A) Sedimentation equilhibm analysis of Al40 dissoved in DMSO at 3 mg/iml (690
MM), centifuged at 60,000 rpm (250,000 x g) for 64 h (6-h intervals between scans) at 23°C. The spike at about 6.15 cm is the solution meniscus To
aculate the moklela weight for a sedimenting compon, indepe nt determiation of the partial specific volume (v) of the protem is requied A seach
of Chemical Abstracts (Chemical Abstract Seravices, American Chemical Society, Columbus, OH) did not reveal any earlier reports of determinations for
proteis m DMSO. When we used the nomeric molecular weight observed by ESI-MS (4325 Da) for A,840 we calclated = 0.859 for monmaner. To
obtain dimer (8650 Da) required = 0.884. (B) equilibium analysis of A,842 dissolved m DMSO at 3 mg/ml (670 pM) under the same
condition as in (A) (at 4-h intervals). As with A,840 we used the molcular weight from ESI-MS (4511 Da) to esfimate that v = 0.858 for A$42 in DMSO.
Dimeric A,342 would reqire that v = 0.883. (C) Sedimentation velocity analysis ofA,40 feshly dissolved in 30% ACN/0.1% TFA at 3 mg/nl centrifuged
at 30,000 rpm (65,000 x g) for 1 h (at 12-min intervals) at 23°C. (D) Sedimentatio velocity analysis of Af342 freshly dissolved in 30% ACN/0.1% TFA
at 3 mg/ml centrfuged at 3000 rpm (650 x g) for 1 h (4-min intervals) at 23°C. The large amount of noise on the raw data could be attribted to oil deposits
on the optical system of the XL-A uracentifuge. This noise limits our ablty to esimate parameter uncertainties on the measurements, but does not perturb
the trends in the results that we presenL
microfuge centrfugation employed to remove insoluble ma-
terial. We consider these species to be "soluble aggregates"
that form an optically cdear solution and can be easily mis-
taken for monomeric A,3. Some material did not sediment at
the higher rotor velocity; note that the baseline did not reach
0 at 30,000 rpm (Fig. 3 B). Analysis of the nonzero baseline
indicated that the remaining material was monomeric.
As a comparison, Af340 was dissolved in DMSO and then
diluted into PBS. After 3 days, the 230 FAM A,i solution
exhibited an s -30 S (data not shown) very similar to the
soluble aggregates observed in the solution aged after direct
dissolution in PBS. This size probably represents a size limit
of "soluble aggregates" before larger structures were formed.
In a more detailed analysis (Fig. 4), the sedimentation
velocity data at 30,000 rpm were fit to the model of Fujita
(1962). The data could be fit better by a model that consid-
ered two sedimenting species rather than one (compare Fig.
4 A with 4 B). The two-component model yielded diffusion
coefficients that correlated better with values expected from
the aggregates sizes estimated from the sedimentation co-
efficients. Uncertainties in calculating the diffusion coeffi-
cient arise because the one component model must overes-
timate the diffusion coefficient to account for the boundary
broadening that actually develops from the size distribution
of aggregates (Holzman and Snyder, 1994). A comprehen-
sive model of the aggregate sedimentation velocity behavior
would likely encompass a Gaussian distribution of aggregate
sizes based on polymer chain elongation (Demas and
DeGraff, 1993). However, the signal-to-noise ratio for the
Af3 sedimentation data was insufficient for such an approach,
and it was not attempted.
The data were subjected to the analysis methods of
Stafford (1992a,b) to calculate the apparent sedimentation
coefficient distnrbutions (g*(s),; Fig. 5). The distnrbution ex-
hibited a broad maximum in the region of s = 27 S with a
full-width-half-maximum over the range, 17-42 S. Contri-
butions decreased steadily with increasig s, and there was
very little contribution from species with s <15 S. These
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FIGURE 2 Sedimentation analyses of A1440 dissolved in distiled H,O.
(A) Sedimentation equihibrium analysis of 350 #LM A(340 aged in H,O for
1 day, centifuged at 3000 rpm for 22 h at 23°C. Fitted acrve through the
data gave an Mw value of 8.5 x 105. (B) Sedimentation velocity analysis
of 900 p1M Af840 aged 1 month in H20 analyzed at 3000 rpm, 23°C. Optical
transient were colected at 4-h intervals at the indicated times. Solid thick
lines through the data indicate the single-component fits to Eq. 1.
resu s suggest that the "soluble aggeg forms a quasi-stable
species with a fiite distribution ofaggregat sizes, and therefore
that a distibution of aggregate sizes does not exist
The form of the final aggrgated state
Samples for transmission electron microscopy were taken
directly from the samples prepared for analysis of aggrega-
tion kinetics. Densely packed fibrils were observed with
AS40, A1340 M[OJ, and Af842. Fibrils had diameters ofabout
5 nm and lengths of about 100 nm (Fig. 6). In comparison,
the revere sequence 40-1 exhitd large amorphous globles
when handled with idenical proce& & The fibrillr strwurte
for A4340 was simila at pH 4.1 and pH 7.4 (not shown).
Kineics of amyloid aggregation.
Monitoring A43 aggregation by turbidity measurements pro-
vides a picture of the overall concentration of aggregated
peptide. Choice ofwavelength affects the subset of sizes that
are monitored (Doty and Steiner, 1950), but little information
regarding the number, size, or shape of the aggregates can be
discerned from single-wavelength, single-angle presenta-
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FIGURE 3 A1340 (2 mg/mi, 450 tLM) dissolved and aged in PBS (50mM
phosphate, 150 mM NaC, pH 7.40), 23°C. Optical transients collected at
280 nm. (A) Rotor velocity of 3000 rpm (650 x g) presented at 6-min
intervals showing the sedimentation of large aggregates. Sedimentation
analysis of these aggregates gave a sedimentation coefficient of 50,000 S.
(B) Rotor velocity of 30,000 rpm (65,000 x g) presented at 4-mm intervals
showing the sedimentatio of smaller, "soluble' aggregates. Analysis
yielded s -30 S. From the indicated absorbance the relative contribtions
of large aggregates, soluble aggrgates, and small species can be estimated.
the rate that small Aj3 species enter the aggregated state can
be followed. We present these results without modeling the
kinetics as a guide to monitoring A,B aggregation behavior.
In Fig. 7, we present a comparative pH study of the ag-
gregation kinetics of the Afl40, Afl40 M[O1, and A(342. For
A(340, aggregation was rapid (seconds) at pH 5 and 6,
whereas at pH 4 it was slow (hours). At pH 7.0 and 7.40,
aggregation was extremely slow (days). A640 M[O] exhib-
ited similar behavior as its unmodified analog, but kinetics
were faster in all cases. AJ342 aggregated more rapidly than
A(340 over the entire pH range investigated; complete ag-
gregation was observed within 1 min at all pH values studied.
The aggregation kinetics of A(3 1-43 were very similar to
AJ342 (data not shown).
The dramatic enhancement of aggregation rate observed
with AJ342, in comparison with A840, suggests that the hy-
drophobic carboxy terminus of A(3 plays a critical role in
aggregation. Lansbury and co-workers (Spencer et al., 1991;
Jarrett and Lansbury, 1993; Jarrett et al., 1993) have sug-
gested that structural ordering of the carboxy terminus is the
rate-determining step for ABl aggregation. The pH depen-
dence of the kinetics reveals that the charged amino terminus
and central region of the peptide must also be involved in
Sndret a. 1221
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FIGURE 4 Analysis ofsedimentationvelocity data for2mg/ml (450 JLM)
Af4O disled and aged in PBS (50 mM phosphate, 150 mM NaCI, pH
7.40 ,0 23°C
through the data indicae the single componet fits. (Inset) Analyi of data
of (poor) single-mponnt fits for sedimentation and diffusion coeffiints
acording to Eq. 1. Sedimentaion coefint, nm Svedbegs ( a dif-
fUsn coefficient (0)mi Fscks.IMe analysis yielded an average s =32S
and an avelage d = 72 F. The magnitude of the diffusion coefficient does
not correlate well with the sedimentaion coefficient (B) Reanalysi (solid
thick lines) of the identical data with a two-cmonent fit for sedimentation
and diffusion coefficients aoing to Eq. 1. (I nset) Analysis of datafrom
two-component fits of sedimentatio and diffusion coefficients accordg to
Eq.. Solid thick line tthrough the datn indiate the (good) two-) pnent
fits. The analysis yielded two cmponents with a 2:1 contarbuton with s =
28 and 64S, respectively. Tehediffusion coefficients were still oveestimated
(35 and 110 F), indicating that althoug the fit quaty seemed satyiso,
there was a failure to fit a model with discrete components.
aggregation. Given our findings that A n40 M[Of, which
contains a more polar group in the middle of the hydrophobic
region, aggregates fasterth ththe normal peptide, it may be
premature to fouls solely on the conformation of the carboxhy
terminal residues as controlling the rate of aggregation.
Aggregation likely requiires interactions along much of the
A3 chain. An antipllel sheet requires head-to-tail ori-
entation so the carboxy terminus cannot exclusively control
aggregation.
We have other corroborating evidence indicating that ag-
gregation is dependent upon much of the AJ3 sequence.
Chemical modification ofAn340 inhibited aggregation under
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FIGURE 5 Apparent sedimentation coefficient distrliion (g*(s),) as a
function of sedimentatio coefficient The data from Fig. 4 were fit i
"ddt" from Stafford (1992a,b) over the time range 38-63 mm with A =
15 min. g*(s), exhibited a broad maximum near s = 27 S and a full-width-
half-maimum over the range 17-42 S. The analysis is uncorrcted for
diffusion.
conjugation of fluorescein to the amino terminal Asp-1 and
iodination of Tyr-10 inhibited aggregation (data not shown).
These modifications are remote from the carboxyl terminus
of A,3 and further point to the involvement of the entire
molecule in controlling aggregation.
To understand further the factors that control A,3 aggre-
gation, we studied the starting solvent, concentration, tem-
perature, and ionic strength effects on aggregation kinetics.
In Fig. 8, we show that A(340 aggregation kinetics exibit a
strong nonlinear dependence on peptide concentration. Ag-
gregation exhibits threshold-type behavior, where rates are
dramatically enhanced once a given sample concentration is
reached This behavior indicates that the rate-determining
step is the formation of a multimeric seed or initiator
(Hofrichter et al., 1974; Jarrett and Lansbury, 1992, 1993).
When starting from HFIP, a solvent in which A,640 re-
mains monomeric, aggregation kinetics increased by a factor
of -10 in comparison with DMSO (Fig. 8 B). In HFIP, A,8
is reported to be a mixture of random coil and a-helix with
litfle-to-no e-sheet character (Hilbich et al., 1991; Barrow
et al., 1992). Increased aggregation probably arises from the
decreased hydrogen bonding, and therefore, decreased sol-
vation by HFIP. This variation in aggregation behavior por-
tends the difficulties in correlating A43 aggregation and struc-
ture to toxicity.
TIhe dependence of A(340 aggregation on solution ionic
strength is presented in Fig. 9 for a series of NaCl concen-
trations (0-500 mM). Aggregation is strongly accelerated by
increasing salt concentration, again revealing the depen-
dence of aggregation properties on handling conditions. In
addition, aggregation is weakly dependent upon temperature,
increasing as the temperature is raised from 10 to 370C (data
1222 Bo sca Joia
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FIGURE 6 Transmmm electon micrgrapns of (A) A4340, (B)A4 M¶OJ (C) A342, and (D) 40-1 peptide. Samples were diuted out ofDMSO into
the wide-range pH buffer at pH 4.1 and aged for 1 week at 45 Individua samples were placed on form var cabon specimen grids and negatively stained
with 2% acid for 1 min. All grids wee examined with a CM12 TEM opeAug at 80 kV and 6Q,000x m laeitwined i,ls of about
5 rn di{amn and vaiabk lengths (-100 nm) were odcved in all the A,l samples. With the revene squane 40-, onlyanmp gk*ls wered aved
not shown). Taken together, the ionic strength and tempera-
ture dependence indicate that aggregation is driven by a hy-
drophobic effect (Hilbich et al., 1991).
Inhibition of Af642 aggregation and seeding of Af340 ag-
gregation. Given the large differences in aggregation rates
for Af840 and AJ642 under identical conditions, we investi-
gated the aggregation rates when A>340 and Af342 were
mixed at several pH values (Fig. 10 A) and peptide concen-
trations (Fig. 10 B). A significant concentration-dependent
decrease in rate was observed forAfr42 aggregationwhen the
two were mixed With the mixture, the turbidity signal in-
creased from an early time level near baseline without the
rapid rise observed for A4342 by itself. These results cannot
be attnbuted to rapid aggregation of Afr42 followed by a
Snye et al. 12 3
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FIGURE 7 Agggaion kinetics of (A) A340, (B) A4340 M[OJ, (C)
AN42 at several pH values Samples were diluted out ofDMSO at 30 mg/mil
(6.5 mM) to a final concentratio of 0.2 mg/mi (45 pM) in eithr the wide-
range pH buffer (pH 4.1, 5.0, 6.0, and 7.0) or PBS (10mM phopht, 150
mM NaCI, pH 7.40) and rapidly mixed. Turbidity was monhored in 0.5-an
path length cells at 37C with an HP8452 diode array e r
Dilution from DMSO into buffer was perfomed about 30 s before the start
of data collectio In cases where aggregion was rapid (second), shift n
turbidity were fruhently obseved (e.g, A4340 M[Ol at pH 5.0), which can
probably be attributed to settling of large tes
seeding of A340 aggregation by aggrgated Af42. Instead,
the rate retardation observed with a mixture of Afr42 and
A1340 must be atibuted to inhibition of Afr42 aggregation
when the two are mixed together.
We continued these mixig experiments by investigating
the effect of several A8 hfagments (1-28,25-35, 30-40, and
30-42) or the reverse sequence peptide (40-1) on aggrega-
tion kinetics of A1842 (Fig. 11). Only a slight inhibition of
aggregation was observed in most cases. This is probably due
to nonspecific interactions between intact A4f42 and the frag-
ments (or 40-1). There was also only a slight inhibition of
aggregation in the presence of 20%o bovine serum albumin
(data not shown). A( 1-28 was intermediate in its effec-
tiveness at inhibiting Afr42 aggregation (Fig. 11). A com-
bination of A(3 fragments, 1-28 and 30-40, (also 30-42), did
not retard A$42 aggregation to any greater extent than
the separate fragments; in fact, inhibition was less than
that observed for intact Afl40. Taken together these data
suggest that both specific inhibition of aggregation, and
aggregation itself, rquired interactions along the whole
peptide sequence.
FIGURE 8 Concentation kinetics of A340 in
PBS (10mM ph e, 150mM NaCl, pH 7.40) Turbidity was monitored
in 1.0-am path length cels at 350 am at 20'C. (A) A1340 was diluted out
of DMSO at 30 mg/ml to the indicted conenations, 45-430 p.M (0.2-
>2 mg/mi) (Inset) The low conmtration regime (' 220 pM) is expanded
to reveal the L-xk of at the low Agggation
exhibited a stong upon concendtation, i ting that
a threshold exists for rapid (B) A4340 was diluted out of HFEP
(65 mM) to the indicatedn 10-200 AM (0.04-0.8 mg/mi).
(Inset) The low atinr (' 20 pM) was expnded to reveal
the lack of at low concent HFIP e-
hibited similar drshold behavior, but at _ that were an order
of magnitu les than that from DMSO.
From the mixing experiments it is apparent that A,B40 and
A1342 interacted during the aggregation process. To study the
interactions between aggregated and aggregating peptide, we
studied the ability of preformed aggregates of A(342 to seed
the aggregation of 45 FLM A1340 (Fig. 12). By itself A,340
aggregates very slowly (Fig. 12A). In the presence of 11 pLM
agggated A842, the rate of A1340 aggregation increased
dramatically (minutes, Fig. 12 B), and in the presence of 45
jLM AJ342, A,840 aggregated in seconds (Fig. 12 C). In Fig.
12 D we show that the increase in turbidity observed in Fig.
12 C cannot be attributed to agitation of aggregated Af342
that has deposited in the cuvette. Therefore, aggregation of
A,340 is enhanced by several orders of magnitude in a dose-
dependent fashion when seeded with aggegated Af842. As
we first noted (Snyder et al. 1993a) and as confirmed by
Jarrett et al. (1993), aggregated A1342 is capable of initiating







































0.0 . @ sl | _' I >0 10 20 30
Time (min)
FIGURE 9 Ionic stength dependence ofthe aggtion kinetics ofA$40
diluted fir HFIP into PBS (10 mM pho e, p1 7.40) and varying
concentratioa s ofNaG (0-500 mM) Turbidity wasm d in 1-cm path
length cells at 350 mm at 20°C at 68 LM Aj340. Aggregation was strongly
- upon salt concentation agbain g teshold behavior. The
salt concentatio required forrrapidagatim was much smaller at higher
A340 c aions (data not shown).
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FIGURE 10 A p inetis of A,842 mixed with Af340. The two
Af sampleswere mixed in DMSO (each at 15 mg/ml) and diluted into either
the wide-range buffer or PBS (10mM ophate, 150mM NaC, pH 7.40)
Turbidity was monitored in 0.5-an path length cells at 37°C (A) Depen-
dence ofinh onof on pH at 4.1, 5.0, 6.0, 7.0, and 7.4) on
samples with 0.2 mg/mi (45 pJL) of both Al40 and Aa42. (B) Concen-
tratio dependence of the inb n of aggregation at pH 7.0. A342 con-
centrations were held at 0.2 mgnml, wbereas A$40 concentraions were
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FIGURE 11 Inhibiton of A$42 agegaton by the idicated A8flrag-
ments (or the 40-1 peptide) mixed in DMSO and diluted into pH 7.0 wide-
range buffer. Turbidity was monhored in 0O5-an path klgth cells at 37C.
All peptide concentations were held at 50 ILK The control had Afr42
without any added fr 0 had the most dramatc effect on A4142
agBgregation AJ3 1-28 had an inmediate effect, and the smaller AP frag-
ments and 40-1 had only small effects. The combinati of A$8 1-28 and










|:I A) OILM -C) 45 gM
|-B) II IpM -D) ei
0 10 20 30 40 50
Time (min)
FIGURE 12 Seeding of 02 mge/mI (45 PM) Aj340 aggregation by A,642
in PBS (10mM ph e, 150mM NaCI, pH 7.40) A342 was diluted fron
DMSO (30 mg/ml) and aLlwed to for 1 hat 0.2 mg/mi (45 pM)
inPBS at37C Afl40wasdutedfi DMSO (30mgml) into the indicated
solutions. Turbidity was monitored on 1.0-cm path lengh cells at 23°C. A)
A4340 diluted into PBS withKt A342. B)A340 diluted into 0.05 mg/mi (11
pM) A1342 (aggegated at 0-2 mgmi) (C) A4340 diluted into 0.2mg/mI (45
JLM) A8l42. Aggrgatio kinetics ofA40 ae enhanced by the prsence of
aggegated A,842 in a dos-dependent manne. (D) The a t 02
mg/mI (45 pJM) AP42 solution was mmxed m the same fashion as Aj4
was added, but no additin of concentrted Aj640 was performed. This
rmixung of agg ated 42 did not increase the signal as observed with
addi of At340.
Factors controlling the
The rate of A4 aggregation is controlled by two distinct fac-
tors. First, solution conditions that decrease solubility and/or
increase (-sheet character accelerate aggregation kinetics;
a ion is controlled by the ability of the appending
monomer to acquire the required stucture for polymeriza-
tion. Lnsbury (1992) has uggested that the two additional
-u.u I i i
.i _ 4- -i i -+ -.
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residues on A,r42, He-Ala, drive the carboxy terminus to-
ward an extended fr-sheet structure that is limited by a cis-
amide isoform at Gly37-Gly38 (Spencer et al., 1991). This
can be seen in the accentuated aggregation rates of Af342 in
comparison with A,340.
Second, aggregation rates are controlled by the number
of sites available for elongation. A,B aggregation/
polymerization exhibits lag time and threshold behavior ob-
served with polymerization processes (Hofrichter et al.,
1974; Jarrett and Lansbury, 1992, 1993). Once nucleating
sites are available, AJ3 aggregates rapidly. In the experiments
with mixed A(340 and A,42, aggregation kinetics were in-
hibited because A(840 prevented nuclei of A,842 multimers
from forming, by a competitive binding mechanism. This
effect is transient in nature because, once the nucleating spe-
cies are formed, both A,342 and A,340 aggregate. In fact,
when more A,340 is present, kinetics are retarded, but the
overall turbidity signal rises well above samples without
A(340.
From the dependence of AJ3 aggregation kinetics on the
ratio of A(840 and A,r42, we speculate that the amount of
accumulated peptide might correlate more closely with either
the relative ratio of the longer to shorter forms of AJ3 than
to overall A$ concentration. Cerebrospinal fluid concentra-
tions of A340 are in the range from high picomolar to low
nanomolar (Seubert et al., 1992; Shoji et al., 1992), signifi-
candly below threshold concentrations required for rapid ag-
gregation (-350 ILM). Considering its sluggish aggregation
rates, unless high concentrations of A(840 develop in local-
ized regions, it is unlikely that a significant amount of AfO40
would aggregate by itself. On the other hand, aggregates of
Afr42 or mixtures of A,342 and Af840 that aggregate in the
seconds-to-minutes time regime would more readily develop
in vivo. This leads to questions regarding cleavage speci-
ficity of the carboxy terminus of ,BPP. Slight changes in
differential processing of the carboxy terminus could have
dramatic effects on the amount of A,B aggregation and
accumulation.
Another factor that can affect aggregation rates is the de-
gree of Met-35 oxidation in A(340 (or possibly AJ342). In a
comparison of aggregation rates for A(340 versus A1340
M[O] (Fig. 7), Met oxidization enhanced aggregation rates.
Oxidation of A,3 by radical damage has been suggested as a
causative agent to AB3 toxicity (Behl et al., 1992; Dyrks et al.,
1992; Hensley et al., 1994); increased aggregation rates
could contnbute to increased toxicity.
Much of the variance observed in A43 toxicity could be due
to the extreme sensitivity of the aggregation process to han-
dling conditions. We have shown that several factors (i.e. AB3
concentration, pH, and ionic strength) require only slight
modification to change aggregation rates dramatically. The
trends in aggregation behavior that we have presented are a
paradigm, but ultimately A(3 toxicity should be correlated
with the aggregation state of the specific samples investi-
gated. Consideration of the aggregation process during ex-
perimental design will avail the investigator increased re-
producibility in toxicity assays.
CONCLUSIONS
We have developed a paradigm for studying the aggregation
behavior of A,3 as it proceeds from a monomeric starting
state to a fibrillar final state. A40 and A,342 remain mo-
nomeric in DMSO or HFIP up to millimolar concentrations
but aggregate heavily in water, PBS, or ACN/FfA, at sub-
millimolar concentrations. In PBS, aggregated A(4 forms
several types of species, including large, probably visible,
aggregates with a sedimentation coefficient of -50,000 S,
small, soluble aggregates with s -30 S, and monomer. Ag-
gregation kinetics are strongly dependent upon sample and
environmental conditions. Aggregation is very rapid (sec-
onds) near the pl of the peptide (pH 5-6). Outside of this
range, aggregation of Af,42 remains rapid (minutes),
whereas A(340 aggregation slows (hours to days). A,B ag-
gregation exhibits ionic strength and temperature depen-
dence indicative of an aggregation being driven by a hy-
drophobic effect. In addition, aggregation of Afl40 displays
threshold-type behavior, which indicates that the rate-
determiniing step is the formation of a multimeric seed. When
mixed together as monomers, A(340 (or other A,B fragments)
and A,342 aggregate at a rate much slower than AJ342 by
itself. This retardation of aggregation rate is dose dependent
and is observed most specifically for A,840. As less of the
intact A,3 structure is retained, peptides are less competent
to inhibit A(342 aggregation. In addition, preformed aggre-
gates of A,842 are capable of seeding Af340 aggregation in
a dose-dependent fashion. The interplay in the aggregation
kinetics of A,340 and AJ342 suggests that relative concen-
trations of A,642 could be a factor in A,B deposition.
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